Precision Biology for Aging-Related Drug Development
- Unlock broader therapeutic impact by addressing the multiple interconnected pathways; immunity, metabolism, inflammation, and repair, that collectively drive aging
- Avoid costly trial failures by moving beyond single-pathway approaches and capturing critical crosstalk that shapes treatment outcomes
- Accelerate precision drug development through panomics, where integrating multiomics data reveals actionable insights to design more effective, aging-targeted therapies